In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

A review of the SPRINT Systolic Blood Pressure Intervention Trial

The Systolic Blood Pressure Intervention Trial (SPRINT) was designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal (120mmHg) than currently recommended (140mmHg) could reduce cardiovascular disease (CVD) risk.

Dr. Marc Ferrini from the Council for Cardiology Practice has contributed this review of the Sprint Trial.

 

An article about the Council for Cardiology Practice (CCP)

Read this CardioPulse article about CCP.

Eur Heart J (2016) 37(19): 1485-1492 DOI: http://dx.doi.org/10.1093/eurheartj/ehw143

 

 

ESC Congress 2016

2015-2016 Year in Cardiology Practice - Take Home messages

 ESC Guidelines

Here are the most recent ESC Guidelines.

Download ESC Guidelines

Atrial Fibrillation 2016 (Management of) download
Dyslipidaemias 2016 (Management of)
download
Acute and Chronic Heart Failure download
Cancer treatments & cardiovascular toxicity 2016 (Position Paper)
download
CVD Prevention in Clinical Practice (European Guidelines on) download

 

Access the full list of ESC Guidelines.